Binnian Wei1, K Udeni Alwis2, Zheng Li2, Lanqing Wang2, Liza Valentin-Blasini2, Connie S Sosnoff2, Yang Xia2, Kevin P Conway3, Benjamin C Blount2. 1. Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: bwei@cdc.gov. 2. Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, United States. 3. Division of Epidemiology, Services and Prevention Research at the National Institutes of Health, United States.
Abstract
BACKGROUND: Marijuana is seeing increased therapeutic use, and is the world's third most-popular recreational drug following alcohol and tobacco. This widening use poses increased exposure to potentially toxic combustion by-products from marijuana smoke and the potential for public health concerns. OBJECTIVES: To compare urinary metabolites of polycyclic aromatic hydrocarbons (PAHs) and volatile organic compounds (VOCs) among self-reported recent marijuana users and nonusers, while accounting for tobacco smoke exposure. METHODS: Measurements of PAH and VOC metabolites in urine samples were combined with questionnaire data collected from participants in the National Health and Nutrition Examination Surveys (NHANES) from 2005 to 2012 in order to categorize participants (≥18years) into exclusive recent marijuana users and nonusers. Adjusted geometric means (GMs) of urinary concentrations were computed for these groups using multiple regression analyses to adjust for potential confounders. RESULTS: Adjusted GMs of many individual monohydroxy PAHs (OH-PAHs) were significantly higher in recent marijuana users than in nonusers (p<0.05). Urinary thiocyanate (p<0.001) and urinary concentrations of many VOC metabolites, including metabolites of acrylonitrile (p<0.001) and acrylamide (p<0.001), were significantly higher in recent marijuana users than in nonusers. CONCLUSIONS: We found elevated levels of biomarkers for potentially harmful chemicals among self-identified, recent marijuana users compared with nonusers. These findings suggest that further studies are needed to evaluate the potential health risks to humans from the exposure to these agents when smoking marijuana. Published by Elsevier Ltd.
BACKGROUND:Marijuana is seeing increased therapeutic use, and is the world's third most-popular recreational drug following alcohol and tobacco. This widening use poses increased exposure to potentially toxic combustion by-products from marijuana smoke and the potential for public health concerns. OBJECTIVES: To compare urinary metabolites of polycyclic aromatic hydrocarbons (PAHs) and volatile organic compounds (VOCs) among self-reported recent marijuana users and nonusers, while accounting for tobacco smoke exposure. METHODS: Measurements of PAH and VOC metabolites in urine samples were combined with questionnaire data collected from participants in the National Health and Nutrition Examination Surveys (NHANES) from 2005 to 2012 in order to categorize participants (≥18years) into exclusive recent marijuana users and nonusers. Adjusted geometric means (GMs) of urinary concentrations were computed for these groups using multiple regression analyses to adjust for potential confounders. RESULTS: Adjusted GMs of many individual monohydroxy PAHs (OH-PAHs) were significantly higher in recent marijuana users than in nonusers (p<0.05). Urinary thiocyanate (p<0.001) and urinary concentrations of many VOC metabolites, including metabolites of acrylonitrile (p<0.001) and acrylamide (p<0.001), were significantly higher in recent marijuana users than in nonusers. CONCLUSIONS: We found elevated levels of biomarkers for potentially harmful chemicals among self-identified, recent marijuana users compared with nonusers. These findings suggest that further studies are needed to evaluate the potential health risks to humans from the exposure to these agents when smoking marijuana. Published by Elsevier Ltd.
Authors: D Robin Taylor; David M Fergusson; Barry J Milne; L John Horwood; Terrie E Moffitt; Malcolm R Sears; Richie Poulton Journal: Addiction Date: 2002-08 Impact factor: 6.526
Authors: Zheng Li; Lovisa C Romanoff; Debra A Trinidad; Erin N Pittman; Donald Hilton; Kendra Hubbard; Hasan Carmichael; Jonathan Parker; Antonia M Calafat; Andreas Sjödin Journal: Anal Bioanal Chem Date: 2014-04-09 Impact factor: 4.142
Authors: Yang Xia; James E McGuffey; Sumita Bhattacharyya; Börje Sellergren; Ecevit Yilmaz; Lanqing Wang; John T Bernert Journal: Anal Chem Date: 2005-12-01 Impact factor: 6.986
Authors: Zheng Li; Courtney D Sandau; Lovisa C Romanoff; Samuel P Caudill; Andreas Sjodin; Larry L Needham; Donald G Patterson Journal: Environ Res Date: 2008-03-03 Impact factor: 6.498
Authors: Binnian Wei; John T Bernert; Benjamin C Blount; Connie S Sosnoff; Lanqing Wang; Patricia Richter; James L Pirkle Journal: Environ Health Perspect Date: 2016-05-10 Impact factor: 9.031
Authors: Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-05-18 Impact factor: 5.464
Authors: Karen M Wilson; Michelle R Torok; Binnian Wei; Lanqing Wang; Michelle Robinson; Connie S Sosnoff; Benjamin C Blount Journal: Pediatr Res Date: 2016-12-02 Impact factor: 3.756
Authors: Xianghua Luo; Steven G Carmella; Menglan Chen; Joni A Jensen; Lynne R Wilkens; Loic Le Marchand; Dorothy K Hatsukami; Sharon E Murphy; Stephen S Hecht Journal: Nicotine Tob Res Date: 2020-10-08 Impact factor: 4.244
Authors: Danielle M Smith; Richard J O'connor; Binnian Wei; Mark Travers; Andrew Hyland; Maciej L Goniewicz Journal: Nicotine Tob Res Date: 2020-07-16 Impact factor: 4.244